The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 18, 2023

Filed:

Feb. 07, 2018
Applicant:

The University of Manchester, Manchester, GB;

Inventors:

Brian Bigger, Manchester, GB;

Hélène Gleitz, Rotterdam, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/63 (2006.01); C07H 21/04 (2006.01); A61K 35/28 (2015.01); C07K 14/775 (2006.01); C12N 5/16 (2006.01); C12N 15/79 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); C07K 14/775 (2013.01); C12N 5/16 (2013.01); C12N 15/63 (2013.01); C07H 21/04 (2013.01); C12N 15/79 (2013.01); C12N 2510/00 (2013.01);
Abstract

The present invention relates generally to polypeptides or nucleic acids for use in the treatment, management, retardation of progression or normalisation of development of an iduronate-2-sulfatase (IDS) deficiency and/or Mucopolysaccharidosis type II (MPS II) in an individual, wherein the polypeptides comprise iduronate-2-sulfatase (IDS) tethered to a tandem repeat of Apolipoprotein E (ApoEII) or the nucleic acids comprise an iduronate-2-sulfatase (IDS) gene sequence tethered to a tandem repeat of the Apolipoprotein E (ApoEII) gene sequence. The invention also relates to haematopoietic stem and progenitor cells (HSPCs) transduced by such nucleic acids for use in therapies.


Find Patent Forward Citations

Loading…